Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin

American Journal of Pathology

Volumn 156, Issue 4, 2000, Pages 1345-1362

  Kim, Semi ^a   Bell, Kelly ^a   Mousa, Shaker A ^b   Varner, Judith A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INTEGRIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL GROWTH; CHICK EMBRYO; COMBINED IMMUNODEFICIENCY; EMBRYO; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033843942     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65005-5     Document Type: Article

References (74)

1. The role of vascular endothelial growth factor in blood vessel formation
2. Angiogenesis in embryos and ischemic diseases
3. Angiogenesis in cancer, vascular, rheumatoid and other disease
4. Mechanism of angiogenesis
5. Integrins, angiogenesis and vascular cell survival
6. The role of vascular cell integrin αvβ3 and αvβ5 in angiogenesis
7. Defects in mesodermal migration and vascular development in fibronectin-deficient mice
8. Embryonic mesodermal defects in α5 integrin-deficient mice
9. β1 integrin is essential for teratoma growth and angiogenesis
10. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins
11. Heterozygous embryonic lethality induced by targeted inactivation of VEGF gene
12. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
13. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
14. High affinity VEGF binding and development expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
15. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis
16. The FGF family of growth factors and oncogenes
17. Fibroblast growth factors as angiogenesis factors
18. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis
19. Involvement of interleukin-8, vascular endothelial growth factor and basic fibroblast growth factor in tumor necrosis growth alpha dependent angiogenesis
20. Regional suppression of the extracellular domain of the flt-1 vascular endothelial growth factor receptor
21. In vivo inhibition of angiogenesis and growth of the human U-87 malignant tumor by treatment with an antibody against bFGF
22. Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer
23. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer
24. Interleukin-8 as a macrophage-derived mediator of angiogenesis
25. Inhibition of interleukin-8 attenuates angiogenesis in bronchogenic carcinoma
26. Interleukin-8: A corneal factor that induces neovascularization
27. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in mice
28. Expression of interleukin-8 by human melanoma cells upregulates MMP-2 activity and increases tumor growth and metastasis
29. The CXC chemokines, IL-8 and IL-10, regulate angiogeneic activity in idiopathic pulmonary fibrosis
30. Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung
31. Role of NF-kappa B mediated interleukin-8 expression in intraocular neovascularization
32. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
33. A peptidomimetic antagonist of the integrin αvβ3 inhibits Leydig cell tumor growth and development of hypercalcemia of malignancy
34. Transient functional expression of αvβ3 on vascular cells during wound repair
35. An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularization
36. Definition of two angiogenic pathways by distinct alpha v integrins
37. Suppression of p53 activity and p21WAF1/ClP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis
38. Antibodies to beta 1-integrins cause alterations of aortic vasculogenesis, in vivo
39. Fibronectin: Structure, assemby, and cardiovascular implications
40. Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing
41. The fibronectin isoform containing the ED-B oncofetal domain: A marker of angiogenesis
42. Distribution of oncofetal fibronectin isoforms in normal hyperplastic and neoplastic human breast tissues
43. Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform
44. Control of cell cycle progression by fibronectin matrix architechture
45. Integrins: Versatility, modulation and signaling in cell adhesion
46. Identification and isolation of a 140 kD cell surface glycoprotein with properties expected of a fibronectin receptor
47. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function
48. Mesodermal defects and cranial neural crest apoptosis in α5 integrin-null embryos
49. Integrin α5β1 expression negatively regulates cell growth: Reversal by attachment to fibronectin
50. Selection of peptides binding to the α5β1 integrin from a phage display library
51. Isolation of a highly specific ligand for the α5β1 integrin from a phage display library
52. Use of the ten day old chick embryo model for studying angiogenesis
53. Anti-integrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin
54. Induction of mammary tumors by expression of polyoma middle T oncogene: A transgenic mouse model for metastatic disease
55. Del-1 induces integrin signaling and angiogenesis by ligation of αvβ3
56. Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule
57. Alignment of biologically active domains in the fibronectin molecule
58. Growth factor production by human colon carcinoma cell lines
59. Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src
60. Angiogenesis promoted by vascular endothelial growth factors: Regulation through α1β1 and α2β1 integrins
61. Endothelial cell integrin α5β1 expression is modulated by cytokines and during migration in vitro
62. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphav beta3 integrin, osteopontin, and thrombin
63. Function and receptor specificty of a minimal 20 kilodalton cell adhesive fragment of fibronectin
64. Embryonic lethal mutation in mouse collagen 1 gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death
65. Extracellular matrix and cell shape: Potential control points for inhibition of angiogenesis
66. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis
67. Vitronectin decreases microvascular endothelial cell apoptosis
68. The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin
69. Fibrinogen is a ligand for integrin ≱β1 on endothelial cells
70. Integrins and GTPases in tumour cell growth, motility and invasion
71. Integrin αvβ3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor α5β1
72. The αvβ3 integrin regulates α5β1-mediated cell migration toward fibronectin
73. Vascular endothelial growth factor induced by hyoxia may mediate hypoxia-initiated angiogenesis
74. Spatial and temporal expression ofangiogenesis molecules during tumor growth and angiogenesis